CXCR4-mediated osteosarcoma growth and pulmonary metastasis is promoted by mesenchymal stem cells through VEGF

Oncology Reports

Volumn 30, Issue 4, 2013, Pages 1753-1761

  Zhang, Peng ^a,b   Dong, Ling ^c   Yan, Kang ^a   Long, Hua ^a   Yang, Tong Tao ^a   Dong, Ming Qing ^c   Zhou, Yong ^a   Fan, Qing Yu ^a   Ma, Bao An ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Urumqi General Hospital   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

CXCR4; Mesenchymal stem cells; Metastasis; Osteosarcoma; VEGF

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; PLERIXAFOR; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TUMOR GROWTH; WESTERN BLOTTING;

ANIMALS; BONE NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; HETEROCYCLIC COMPOUNDS; HETEROGRAFTS; HUMANS; LUNG NEOPLASMS; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; OSTEOSARCOMA; RECEPTORS, CXCR4; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84882617861     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2619     Document Type: Article

References (38)

1. Murphey MD, Robbin MR, McRae GA, Flemming DJ, Temple HT and Kransdorf MJ: The many faces of osteosarcoma. Radiographics 17: 1205-1231, 1997.
2. Link MP, Goorin AM, Miser AW, et al: The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 314: 1600-1606, 1986.
3. Chen X, Yang TT, Wang W, et al: Establishment and characterization of human osteosarcoma cell lines with different pulmonary metastatic potentials. Cytotechnology 61: 37-44, 2009.
4. Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF and Keiliss-Borok IV: Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 17: 331-340, 1974.
5. Austin TW, Solar GP, Ziegler FC, Liem L and Matthews W: A role for the Wnt gene family in hematopoiesis: expansion of multilineage progenitor cells. Blood 89: 3624-3635, 1997.
6. Dexter TM, Spooncer E, Schofield R, Lord BI and Simmons P: Haemopoietic stem cells and the problem of self-renewal. Blood Cells 10: 315-339, 1984.
7. Reya T, Duncan AW, Ailles L, et al: A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423: 409-414, 2003.
8. Karnoub AE, Dash AB, Vo AP, et al: Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449: 557-563, 2007.
9. Coussens LM and Werb Z: Inflammation and cancer. Nature 420: 860-867, 2002.
10. Oda Y, Yamamoto H, Tamiya S, et al: CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis. Mod Pathol 19: 738-745, 2006.
11. Li D, Dai K and Tang T: Effects of dextran on proliferation and osteogenic differentiation of human bone marrow-derived mesenchymal stromal cells. Cytotherapy 10: 587-596, 2008.
12. Pittenger MF, Mackay AM, Beck SC, et al: Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147, 1999.
13. Liang Z, Wu T, Lou H, et al: Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res 64: 4302-4308, 2004.
14. Kempf-Bielack B, Bielack SS, Jurgens H, et al: Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). J Clin Oncol 23: 559-568, 2005.
15. Kim J, Takeuchi H, Lam ST, et al: Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J Clin Oncol 23: 2744-2753, 2005.
16. Retz MM, Sidhu SS, Blaveri E, et al: CXCR4 expression reflects tumor progression and regulates motility of bladder cancer cells. Int J Cancer 114: 182-189, 2005.
17. Russell HV, Hicks J, Okcu MF and Nuchtern JG: CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases. J Pediatr Surg 39: 1506-1511, 2004.
18. Wada T, Isu K, Takeda N, Usui M, Ishii S and Yamawaki S: A preliminary report of neoadjuvant chemotherapy NSH-7 study in osteosarcoma: preoperative salvage chemotherapy based on clinical tumor response and the use of granulocyte colony-stimulating factor. Oncology 53: 221-227, 1996.
19. Beckermann BM, Kallifatidis G, Groth A, et al: VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Br J Cancer 99: 622-631, 2008.
20. Djouad F, Plence P, Bony C, et al: Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102: 3837-3844, 2003.
21. Gunn WG, Conley A, Deininger L, Olson SD, Prockop DJ and Gregory CA: A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: a potential role in the development of lytic bone disease and tumor progression in multiple myeloma. Stem Cells 24: 986-991, 2006.
22. Otsu K, Das S, Houser SD, Quadri SK, Bhattacharya S and Bhattacharya J: Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells. Blood 113: 4197-4205, 2009.
23. Potier E, Ferreira E, Andriamanalijaona R, et al: Hypoxia affects mesenchymal stromal cell osteogenic differentiation and angiogenic factor expression. Bone 40: 1078-1087, 2007.
24. Romieu-Mourez R, Francois M, Boivin MN, Bouchentouf M, Spaner DE and Galipeau J: Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype. J Immunol 182: 7963-7973, 2009.
25. Aboody KS, Brown A, Rainov NG, et al: Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA 97: 12846-12851, 2000.
26. De Palma M, Venneri MA, Roca C and Naldini L: Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat Med 9: 789-795, 2003.
27. Xu WT, Bian ZY, Fan QM, Li G and Tang TT: Human mesenchymal stem cells (hMSCs) target osteosarcoma and promote its growth and pulmonary metastasis. Cancer Lett 281: 32-41, 2009.
28. Bachelder RE, Wendt MA and Mercurio AM: Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res 62: 7203-7206, 2002.
29. Plate K: From angiogenesis to lymphangiogenesis. Nat Med 7: 151-152, 2001.
30. de Nigris F, Balestrieri ML, Williams-Ignarro S, et al: Therapeutic effects of autologous bone marrow cells and metabolic intervention in the ischemic hindlimb of spontaneously hypertensive rats involve reduced cell senescence and CXCR4/Akt/eNOS pathways. J Cardiovasc Pharmacol 50: 424-433, 2007.
31. de Nigris F, Crudele V, Giovane A, et al: CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy. Proc Natl Acad Sci USA 107: 14484-14489, 2010.
32. Lin F, Zheng SE, Shen Z, et al: Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma. Med Oncol 28: 649-653, 2011.
33. Balkwill F: The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 14: 171-179, 2004.
34. Busillo JM and Benovic JL: Regulation of CXCR4 signaling. Biochim Biophys Acta 1768: 952-963, 2007.
35. Laverdiere C, Hoang BH, Yang R, et al: Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma. Clin Cancer Res 11: 2561-2567, 2005.
36. Lee YH, Tokunaga T, Oshika Y, et al: Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma. Eur J Cancer 35: 1089-1093, 1999.
37. Murakami T, Maki W, Cardones AR, et al: Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res 62: 7328-7334, 2002.
38. Perissinotto E, Cavalloni G, Leone F, et al: Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression. Clin Cancer Res 11: 490-497, 2005.